Dental Care Clinics in Madison, ME Accepting Medicare
1 Dental Care Clinics found. Showing 1 - 1
 Dr Andrew D Friedman Dmd Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 21 Old Point Ave, Madison, ME 04950 Phone: 207-696-4681 Fax: 207-696-5345 |
News Archive
New chemical agent, MCP110, provides synergistic effect to standard drugs
Integrating the use of drugs targeted to specific cancer proteins into current chemotherapy regimens to improve the efficacy of systemic treatment is an important clinical goal at Fox Chase Cancer Center.
EMA CHMP issues positive opinion to Savient's KRYSTEXXA for treatment of chronic gout
Savient Pharmaceuticals, Inc. and its wholly owned subsidiary, Savient Pharma Ireland Limited, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has completed its scientific assessment and has issued a positive opinion recommending approval of a marketing authorization in the European Union for KRYSTEXXA for the treatment of severe debilitating chronic tophaceous gout in adult patients who may also have erosive joint involvement and who have failed to normalize serum uric acid with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these medicines are contraindicated.
Breast cancer drug Herceptin a 'stunner'
According to the New England Journal of Medicine (NEJM) the first trials of the breast cancer drug, Herceptin, tested on women with early stage disease are "simply stunning".
St. Luke's Miners Memorial Hospital and The Seltzer Group collaborate to provide medical insurance solutions
Schuylkill County's The Seltzer Group, a member of Keystone Insurers Group, announces it has formed an alliance with St. Luke's Miners Memorial Hospital to provide medical insurance solutions and occupational health services to businesses in Luzerne, Carbon and Schuylkill Counties.
Neuroprotective compounds can limit damage to the brain during ischemic stroke
In the 1990s, neuroscientists identified a class of drugs that showed promise in the area of stroke. NMDA receptor antagonists could limit damage to the brain in animal models of stroke. But one problem complicated testing the drugs in a clinical setting: the side effects included disorientation and hallucinations.
› Verified 1 days ago